EMEA (Europe, Middle East and Africa) Anticoagulants Market 2017 Forecast to 2022
Market Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce
coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals
such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the
animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for
thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and
various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in
medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis
equipment.
Scope of the Report:
This report focuses on the Anticoagulants in EMEA market, covering Europe, Middle East and Africa, This
report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
Market Segment by Regions, regional analysis covers
Europe (Germany, France, UK, Russia, Italy and Turkey)
Middle East (Saudi Arabia, Israel, UAE and Iran)
Africa (South Africa, Nigeria, Egypt and Algeria)
Market Segment by Type, covers
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others